Moreover, atorvastatin treatment decreased tumor growth and weight in an HCC xenograft animal model, which were associated with decreased IL-6 and TERT expression and STAT3 phosphorylation and increased β-gal expression and SA-β-gal activity in tumors. This evidence concerns the gene TERT and hepatocellular carcinoma.